We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s User Fee Proposal Places Greater Emphasis on Drug Safety
FDA’s User Fee Proposal Places Greater Emphasis on Drug Safety
January 11, 2007
Improved drug safety is foremost in the FDA’s Prescription Drug User Fee Act (PDUFA) proposal that seeks new authority and more than $29 million in additional fees specifically to improve its postmarket safety surveillance.